Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseasesRenaud Felten, Laurent Arnaud, Maxime Dubois et al.|The Lancet Rheumatology|2021Cited by 125
Refining “Long-COVID” by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 InfectionMarc Scherlinger, Jean Sibilia, Alexandre Bélot et al.|Infectious Diseases and Therapy|2021Cited by 78
Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG StudyMarc Scherlinger, Renaud Felten, Luc Pijnenburg et al.|Vaccines|2021Cited by 47
Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseasesRenaud Felten, Laurent Arnaud, Maxime Dubois et al.|Lara D. Veeken|2021Cited by 29
B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologicsRenaud Felten, Jacques‐Eric Gottenberg, Pierre‐Marie Duret et al.|Annals of the Rheumatic Diseases|2021Cited by 20